Heparin-induced thrombocytopenia in the ICU: an overview
Author:
Open Access
- 1 January 2011
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 15 (2) , 211
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Platelet factor 4/heparin antibody (IgG/M/A) in healthy subjects: a literature analysis of commercial immunoassay resultsJournal of Thrombosis and Thrombolysis, 2008
- The Approach to Heparin-Induced ThrombocytopeniaSeminars in Respiratory and Critical Care Medicine, 2008
- BivalirudinThrombosis and Haemostasis, 2008
- Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT) – Bridging the River CoumarinThrombosis and Haemostasis, 2008
- Fondaparinux for the treatment of patients with acute heparininduced thrombocytopeniaThrombosis and Haemostasis, 2008
- PF4 ENHANCED assay for the diagnosis of heparin-induced thrombocytopenia in complex medical and surgical patients*Critical Care Medicine, 2007
- Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT AntibodiesArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosisThrombosis and Haemostasis, 2005
- Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole bloodThrombosis and Haemostasis, 2004
- Heparin-Induced Thrombocytopenia and ThrombosisNew England Journal of Medicine, 1995